Welcome, Guest. Please login or register.
November 20, 2017, 03:05:42 AM

Login with username, password and session length

  • Total Posts: 722495
  • Total Topics: 58711
  • Online Today: 325
  • Online Ever: 1421
  • (August 13, 2016, 05:18:44 AM)
Users Online
Users: 2
Guests: 279
Total: 281


Welcome to the POZ Community Forums, a round-the-clock discussion area for people with HIV/AIDS, their friends/family/caregivers, and others concerned about HIV/AIDS.  Click on the links below to browse our various forums; scroll down for a glance at the most recent posts; or join in the conversation yourself by registering on the left side of this page.

Privacy Warning:  Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If you are HIV positive and disclose this in our forums, then it is almost the same thing as telling the whole world (or at least the World Wide Web). If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.

  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.

  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.

  • Forums members must behave at all times with respect and honesty. Posting guidelines, including time-out and banning policies, have been established by the moderators of these forums. Click here for “Am I Infected?” posting guidelines. Click here for posting guidelines pertaining to all other POZ community forums.

  • We ask all forums members to provide references for health/medical/scientific information they provide, when it is not a personal experience being discussed. Please provide hyperlinks with full URLs or full citations of published works not available via the Internet. Additionally, all forums members must post information which are true and correct to their knowledge.

  • Product advertisement—including links; banners; editorial content; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from POZ.

To change forums navigation language settings, click here (members only), Register now

Para cambiar sus preferencias de los foros en español, haz clic aquí (sólo miembros), Regístrate ahora

Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.


0 Members and 1 Guest are viewing this topic.

Offline red_Dragon888

  • Member
  • Posts: 2,840
  • Love and Be Love in Return


Author: Mark Mascolini
22 February 2013

US military beneficiaries diagnosed with HIV and cared for early in the course of infection had a neurocognitive impairment rate similar to that of a matched group of military beneficiaries without HIV. The findings suggest that early HIV diagnosis and management may forestall development of neurocognitive problems in HIV-positive people.

Neurocognitive impairment remains frequent among people with HIV infection despite good responses to combination antiretroviral therapy. Because there is little information on how the timing of HIV diagnosis and management affects development of neurocognitive impairment, US researchers planned this analysis of military beneficiaries. Everyone entering the US military is HIV negative and undergoes regular mandatory HIV testing.

The investigators divided the 200-person HIV group into those with shorter and longer durations of HIV infection. They defined shorter-duration HIV as infection for fewer than 6 years, no AIDS-defining conditions, and a CD4-cell nadir above 200 cells/µL. Study participants with longer-duration HIV infection did not meet any of these criteria. The researchers selected 50 HIV-negative participants, matching them to the HIV group for age, gender, race/ethnicity, and military rank. All study participants received a comprehensive battery of neuropsychological tests to assess neurocognitive impairment

HIV-positive participants had a median age of 36 years. Almost two thirds (64%) were taking combination antiretroviral therapy, which started a median of 1.3 years after HIV diagnosis at a median CD4 count of 333 cells/µL (interquartile range [IQR] 248 to 423). Median CD4 count among HIV-positive participants not taking antiretrovirals was 523 (IQR 417 to 685).

Thirty-eight HIV-positive participants (19%) had neurocognitive impairment, and the rate did not differ significantly between those with earlier HIV infection and later HIV infection (18% versus 20%, P = 0.72). These rates were nonsignificantly lower than the 30% prevalence of neurocognitive impairment in the matched HIV-negative participants.

The researchers note that most HIV-positive participants classified as having longer-duration HIV infection had relatively high CD4 counts and few AIDS-defining conditions. The authors believe the low prevalence of neurocognitive impairment in HIV-positive people diagnosed and cared for early in the course of infection suggests that “early recognition and management of HIV infection may be important in limiting neurocognitive impairment.”

Source: Nancy F. Crum-Cianflone, David J. Moore, Scott Letendre, Mollie Poehlman Roediger, Lynn Eberly, Amy Weintrob, Anuradha Ganesan, Erica Johnson, Raechel Del Rosario, Brian K. Agan, Braden R. Hale. Low prevalence of neurocognitive impairment in early diagnosed and managed HIV-infected persons. Neurology. 2013; 80: 371-379.

Off Crystal Meth since May 13, 2013.  In recovery with 20 months clean time.


Terms of Membership for these forums

© 2017 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.